Archives
Press Releases
advertisement
February 15, 2017
- American Diabetes Association® Launches Online Hub for Insulin Affordability Advocates.
- Data Presented at ATTD 2017 Demonstrate Clinical Advantages of Tandem Diabetes Care Sensor-augmented Pump (SAP) over Medtronic MiniMed SAPs.
- T1D Exchange Investment — Bigfoot Biomedical.
- American Diabetes Association Announces $9.75 million to Six Leading Researchers for the 2017 Pathway to Stop Diabetes Research Grants.
January 18, 2017
December 21, 2016
- FDA Approval of Dexcom’s Non-Adjunctive Indication Triggers a New Era in Diabetes Management. The Dexcom G5 Mobile CGM System is the first and only medical device that is FDA-approved for making daily diabetes decisions without painful finger pricks. See also FDA expands indication for continuous glucose monitoring system, first to replace fingerstick testing for diabetes treatment decisions.
- Bionic pancreas system successfully controls blood sugar without risk of hypoglycemia.
- Novo Nordisk Receives FDA Approval of Tresiba® (insulin degludec injection 100 U/mL, 200 U/mL) for Use in Children and Adolescents With Diabetes. See also Tresiba gets FDA approval to treat children with type 1 and type 2 diabetes.
- OneTouch Vibe™ Plus Insulin Pump Earns FDA Approval and Health Canada License and is First Pump Integrated with the Dexcom G5® Mobile Continuous Glucose Monitor.
advertisement